ES2108862T3 - Diamidas imidocarbonimidicas n,n' substituidas derivadas de hidroxilaminas. - Google Patents
Diamidas imidocarbonimidicas n,n' substituidas derivadas de hidroxilaminas.Info
- Publication number
- ES2108862T3 ES2108862T3 ES93903532T ES93903532T ES2108862T3 ES 2108862 T3 ES2108862 T3 ES 2108862T3 ES 93903532 T ES93903532 T ES 93903532T ES 93903532 T ES93903532 T ES 93903532T ES 2108862 T3 ES2108862 T3 ES 2108862T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- substituted
- same
- carbon
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/13—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Paints Or Removers (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Luminescent Compositions (AREA)
- Detergent Compositions (AREA)
- Seasonings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
SE PROPORCIONAN COMPUESTOS DE FORMULA (I) DONDE R1 ES UN GRUPO ALIFATICO DIVALENTE SUSTITUIDO O NO SUSTITUIDO, DE 1 A 16 ATOMOS DE CARBONO; DONDE LOS SUSTITUYENTES SON MONO O POLY, Y SE SELECCIONAN DEL GRUPO FORMADO POR ALQUILO INFERIOR, ARILO Y ARALQUILO; R3 SE SELECCIONA DEL GRUPO FORMADO POR EL MISMO GRUPO DE VALORES COMO R5; R5 SE SELECCIONA DEL GRUPO FORMADO POR ALQUILO SUSTITUIDO O NO SUSTITUIDO DE 1 CARBONO, DONDE LOS SUSTITUYENTES SON MONO O POLY, Y SE SELECCIONAN DEL GRUPO FORMADO POR ALQUILO INFERIOR, CICLOALQUILO DE 3 NITRO, ALCOXI INFERIOR, ALCOXICARBONILO INFERIOR, ALQUILO INFERIOR DE FENILO, FENILO, MONO Y POLYHALOFENILO, FENOXI, MONO Y POLYHALOFENOXI; R6 Y R7 PUEDEN SER LOS MISMOS O DIFERENTES, Y SON HIDROGENO, ALCANONOILO Y ALCOXIALCANOILO; R7 PUEDE TAMBIEN TENER EL MISMO VALOR QUE R5, Y ES OXIGENO O AZUFRE, M ES 0 O 1, 1 ES 0 O 1, DONDE EL PREFIJO "ALK" DESIGNA MITADES QUE SON CADENA RECTA O CADENA RAMIFICADA, Y EL TERMINO "LOWER" (INFERIOR) DESIGNA DE 1 A 6 ATOMOS DE CARBONO Y EL TERMINO NO MODIFICADO "ALK" SIGNIFICA DE 1 A 24 ATOMOS DE CARBONO, LOS RESPECTIVOS TAUTOMEROS (ORGANOS SITUADOS POR COMPLETO EN UNO DE LOS LADOS DEL ORGANISMO) DE LOS MISMOS, LAS SALES FARMACEUTICAMENTE ACEPTABLES Y SALES ADICIONALES DE LOS MISMOS Y LOS HIDRATOS DE LAS CITADAS SALES Y SALES DE ADICION. TAMBIEN SE PROPORCIONAN METODOS DE PROTEGER A PERSONAS EXPUESTAS A LOS MISMOS DE INFECCIONES ORIGINADAS POR UN ORGANISMO DEL GRUPO PLASMODIUM SP., MYOCOBACTERIUM SP. Y PNEUMOCUSTIS CARINII, MEDIANTE LA ADMINISTRACION A UNA PERSONA EXPUESTA A TAL INFECCION, DE UNA CANTIDAD PROFILACTICAMENTE EFICAZ DE UN COMPUESTO DE LA FORMULA PRECEDENTE. ESTOS COMPUESTOS REDUCEN LA INFECCION DONDE TALES PERSONAS HAN SIDO YA INFECTADAS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/837,258 US5322858A (en) | 1992-02-14 | 1992-02-14 | N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2108862T3 true ES2108862T3 (es) | 1998-01-01 |
Family
ID=25273975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93903532T Expired - Lifetime ES2108862T3 (es) | 1992-02-14 | 1993-01-19 | Diamidas imidocarbonimidicas n,n' substituidas derivadas de hidroxilaminas. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5322858A (es) |
| EP (1) | EP0625967B1 (es) |
| JP (1) | JP3207200B2 (es) |
| KR (1) | KR950700243A (es) |
| CN (1) | CN1057520C (es) |
| AT (1) | ATE157352T1 (es) |
| AU (1) | AU668709B2 (es) |
| CA (1) | CA2129430C (es) |
| CZ (1) | CZ294257B6 (es) |
| DE (1) | DE69313438T2 (es) |
| DK (1) | DK0625967T3 (es) |
| EG (1) | EG20476A (es) |
| ES (1) | ES2108862T3 (es) |
| FI (1) | FI943738A7 (es) |
| GR (1) | GR3025429T3 (es) |
| HU (1) | HU220389B (es) |
| IL (1) | IL104484A (es) |
| MX (1) | MX9300688A (es) |
| NO (1) | NO302616B1 (es) |
| NZ (1) | NZ245865A (es) |
| OA (1) | OA10094A (es) |
| PL (2) | PL173258B1 (es) |
| RU (1) | RU2133737C1 (es) |
| WO (1) | WO1993016037A1 (es) |
| ZA (1) | ZA93974B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4321444A1 (de) * | 1993-06-28 | 1995-01-05 | Bernd Prof Dr Clement | Pharmazeutische Zubereitung |
| US6551614B2 (en) * | 2001-03-14 | 2003-04-22 | Jacobus Pharmaceutical Co., Inc. | Antimalarial N,N′-substituted biguanides derived from hydroxylamines |
| CA2477604A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
| CN1738794B (zh) * | 2002-11-22 | 2010-12-22 | 雅各布斯制药公司 | 双胍和二氢三嗪衍生物 |
| US7256218B2 (en) * | 2002-11-22 | 2007-08-14 | Jacobus Pharmaceutical Company, Inc. | Biguanide and dihydrotriazine derivatives |
| US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| WO2006084033A1 (en) * | 2005-02-03 | 2006-08-10 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
| KR101578949B1 (ko) | 2007-10-08 | 2015-12-18 | 엠엠브이 메디슨즈 포 말라리아 벤처 | 가요성 측쇄를 가지는 항말라리아 화합물 |
| MX2010003972A (es) * | 2007-10-13 | 2010-08-09 | Univ Cornell | Composiciones para producir una respuesta inmune contra para-tuberculosis sub-especie mycobacterium avium. |
| JP5607025B2 (ja) | 2008-04-21 | 2014-10-15 | シグナム バイオサイエンシーズ， インコーポレイテッド | 化合物、組成物およびそれらを作製する方法 |
| CN102088956A (zh) * | 2008-05-09 | 2011-06-08 | 托马有限公司 | 氯胍用于治疗皮肤/粘膜疾病 |
| US10829440B2 (en) | 2015-06-12 | 2020-11-10 | Brown University | Antibacterial compounds and methods of making and using same |
| WO2018106907A1 (en) * | 2016-12-08 | 2018-06-14 | Novatarg, Inc. | Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therary |
| US11555010B2 (en) | 2019-07-25 | 2023-01-17 | Brown University | Diamide antimicrobial agents |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB603070A (en) * | 1946-01-25 | 1948-06-08 | Albert Frederick Crowther | Manufacture of biguanide derivatives |
| GB665680A (en) * | 1948-02-20 | 1952-01-30 | Rhone Poulenc Sa | Improvements in or relating to the production of n-p-chlorophenyl-n-isopropyl biguanide |
| DE824942C (de) * | 1949-01-31 | 1951-12-17 | Ici Ltd | Verfahren zur Herstellung von Biguanidderivaten |
| GB667116A (en) * | 1949-04-25 | 1952-02-27 | Albert Frederick Crowther | Manufacture of biguanide derivatives |
| GB814563A (en) * | 1956-11-15 | 1959-06-10 | Vitamins Ltd | Biguanides |
| GB1270831A (en) * | 1968-11-22 | 1972-04-19 | Beecham Group Ltd | Di-hydro triazine derivatives and processes for their manufacture |
| GB1250531A (es) * | 1969-01-01 | 1971-10-20 | ||
| US3723429A (en) * | 1969-11-06 | 1973-03-27 | Beecham Group Ltd | Di-hydro triazine derivatives |
| US3660394A (en) * | 1970-01-23 | 1972-05-02 | Vitamins Ltd | 4 6-dibenzo-1 2-dihydro-aryloxy-1 3 5-triazines |
| GB1546937A (en) * | 1976-07-29 | 1979-05-31 | Beecham Group Ltd | 2,4-diaminopyrimidine derivatives |
-
1992
- 1992-02-14 US US07/837,258 patent/US5322858A/en not_active Expired - Lifetime
-
1993
- 1993-01-19 KR KR1019940702810A patent/KR950700243A/ko not_active Withdrawn
- 1993-01-19 ES ES93903532T patent/ES2108862T3/es not_active Expired - Lifetime
- 1993-01-19 EP EP93903532A patent/EP0625967B1/en not_active Expired - Lifetime
- 1993-01-19 PL PL93315533A patent/PL173258B1/pl not_active IP Right Cessation
- 1993-01-19 CZ CZ19941964A patent/CZ294257B6/cs not_active IP Right Cessation
- 1993-01-19 PL PL93304776A patent/PL172001B1/pl not_active IP Right Cessation
- 1993-01-19 FI FI943738A patent/FI943738A7/fi unknown
- 1993-01-19 HU HU9401976A patent/HU220389B/hu not_active IP Right Cessation
- 1993-01-19 DK DK93903532.5T patent/DK0625967T3/da active
- 1993-01-19 RU RU94039539A patent/RU2133737C1/ru not_active IP Right Cessation
- 1993-01-19 AT AT93903532T patent/ATE157352T1/de active
- 1993-01-19 WO PCT/US1993/000395 patent/WO1993016037A1/en not_active Ceased
- 1993-01-19 JP JP51407193A patent/JP3207200B2/ja not_active Expired - Fee Related
- 1993-01-19 AU AU34759/93A patent/AU668709B2/en not_active Ceased
- 1993-01-19 CA CA002129430A patent/CA2129430C/en not_active Expired - Fee Related
- 1993-01-19 DE DE69313438T patent/DE69313438T2/de not_active Expired - Fee Related
- 1993-01-22 IL IL10448493A patent/IL104484A/en not_active IP Right Cessation
- 1993-02-08 NZ NZ245865A patent/NZ245865A/en not_active IP Right Cessation
- 1993-02-09 MX MX9300688A patent/MX9300688A/es unknown
- 1993-02-11 EG EG7993A patent/EG20476A/xx active
- 1993-02-12 ZA ZA93974A patent/ZA93974B/xx unknown
- 1993-02-13 CN CN93101894A patent/CN1057520C/zh not_active Expired - Fee Related
-
1994
- 1994-08-12 OA OA60554A patent/OA10094A/en unknown
- 1994-08-12 NO NO942988A patent/NO302616B1/no not_active IP Right Cessation
-
1997
- 1997-11-19 GR GR970403074T patent/GR3025429T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2108862T3 (es) | Diamidas imidocarbonimidicas n,n' substituidas derivadas de hidroxilaminas. | |
| FI891548A0 (fi) | Administrering av monoaminakridiner i kolinergiska bristtillstaond av nervceller. | |
| DE10299048I1 (de) | Verwendung von Adamantan-Derivaten zur Praevention und Behandlung der cerebralen Ischaemie | |
| DE69923849D1 (de) | Quinolin-2-on-derivate verwendbar als antikrebsmittel | |
| PE23196A1 (es) | Compuesto util para tratar infecciones por retrovirus | |
| HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
| DE60015927D1 (en) | Phenylharnstoff und phenylthioharnstoffderivate | |
| NZ506574A (en) | Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism | |
| NZ307505A (en) | Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds | |
| ATE283268T1 (de) | 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission | |
| KR920014810A (ko) | 항균제 | |
| NZ334848A (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases caused by fungi and bacteria | |
| ATE161717T1 (de) | Antivirale mittel | |
| ATE224872T1 (de) | Azetidinonderivate zur behandlung von hcmv entzündungen | |
| MY143605A (en) | Tri-, tetra-substituted-3-aminopyrrolidine derivative | |
| SE7709913L (sv) | Sett att framstella penta peptider | |
| KR920014818A (ko) | 항균제 | |
| HUP9803028A2 (hu) | Ciklusos nitronok és az azokat hatóanyagként tartalmazó gyógyszerkészítmények | |
| IT1213301B (it) | Composizioni per il trattamento del le sindromi da ischemia e riperfusione | |
| KR910018341A (ko) | 신규 α-만노시다제 및 푸코시다제 억제제 | |
| CA2206168A1 (en) | Organic peroxide stabilization with .alpha.-hydroxyalkyl peroxides | |
| IS6115A (is) | Haló afleiður af 9-deoxó-9a-aza-9a-hómerýþrómýsíni A | |
| SE7412163L (es) | ||
| ZA874970B (en) | Derivatives of 2,6-piperazinedione,their preparation processes and the pharmaceutical compositions containing them | |
| HUP0204144A2 (en) | N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 625967 Country of ref document: ES |